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Abstract
Background: Bee venom therapy has been used to treat inflammatory diseases including rheumatoid arthritis in humans
and in experimental animals. We previously found that bee venom and melittin (a major component of bee venom) have
anti-inflammatory effect by reacting with the sulfhydryl group of p50 of nuclear factor-kappa B (NF-κB) and IκB kinases
(IKKs). Since mitogen activated protein (MAP) kinase family is implicated in the NF-κB activation and inflammatory
reaction, we further investigated whether activation of MAP kinase may be also involved in the anti-inflammatory effect
of melittin and bee venom.
Methods: The anti-inflammatory effects of melittin and bee venom were investigated in cultured Raw 264.7 cells, THP-
1 human monocytic cells and Synoviocytes. The activation of NF-κB was investigated by electrophoretic mobility shift
assay. Nitric oxide (NO) and prostaglandin E2 (PGE2) were determined either by Enzyme Linked Immuno Sorbent Assay
or by biochemical assay. Expression of IκB, p50, p65, inducible nitric oxide synthetase (iNOS), cyclooxygenase-2 (COX-
2) as well as phosphorylation of MAP kinase family was determined by Western blot.
Results: Melittin (0.5–5 μg/ml) and bee venom (5 and 10 μg/ml) inhibited lipopolysaccharide (LPS, 1 μg/ml) and sodium
nitroprusside (SNP, 200 μM)-induced activation of c-Jun NH2-terminal kinase (JNK) in RAW 264.7 cells in a dose
dependent manner. However, JNK inhibitor, anthra [1,9-cd]pyrazole-6 (2H)-one (SP600215, 10–50 μM) dose
dependently suppressed the inhibitory effects of melittin and bee venom on NF-κB dependent luciferase and DNA
binding activity via suppression of the inhibitory effect of melittin and bee venom on the LPS and SNP-induced
translocation of p65 and p50 into nucleus as well as cytosolic release of IκB. Moreover, JNK inhibitor suppressed the
inhibitory effects of melittin and bee venom on iNOS and COX-2 expression, and on NO and PGE2 generation.
Conclusion: These data show that melittin and bee venom prevent LPS and SNP-induced NO and PGE2 production via
JNK pathway dependent inactivation of NF-κB, and suggest that inactivation of JNK pathways may also contribute to the
anti-inflammatory and anti-arthritis effects of melittin and bee venom.
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Background
Bee venom therapy has been used to relieve pain and to
treat inflammatory diseases including rheumatoid arthri-
tis in humans [1] and in experimental animals [2]. Bee
venom contains melittin, a 26 amino acid peptide, which
forms an amphipathic helix with a highly charged car-
boxyl terminus [3]. We previously found that bee venom
and its major component, melittin inhibited lipopolysac-
charide (LPS), tumor necrosis factor-α (TNF-α), and
sodium nitroprusside (SNP)-induced NF-κB activation by
preventing p50 translocation through interaction of
melittin and sulfhydryl residue of p50 and/or IκB kinases
(IKKα and IKKβ), and that these inhibit inflammatory
reaction in the development of rheumatoid arthritis [4,5]
through reduction of large amounts of nitric oxide (NO)
and prostaglandins (PGs) which are synthesized systemi-
cally in animal models of arthritis and in patients with
rheumatoid arthritis [6-10].
NF-κB and IKKs have been suggested to play important
roles in the regulation of inflammatory genes, such as,
inducible nitric oxide synthetase (iNOS), cyclooxygenase-
2 (COX-2), cytosolic phospholipase A2  (cPLA2), and
tumor necrosis factor-α (TNF-α). Functionally active NF-
κB exists mainly as a heterodimer consisting of subunits
of the Rel family, and this heterodimer is normally
sequestered in the cytosol as an inactive complex by bind-
ing to inhibitory κB (IκBs) in unstimulated cells [11]. The
mechanism of NF-κB activation involves the phosphor-
ylation of IκBs via IKK activation [12]. Once IκBs are
phosphorylated, they are targeted for ubiquitination and
subsequent degradation by the 26s proteosome [13]. The
resulting free NF-κB is translocated to the nucleus, where
it binds to the κB binding sites in the promoter regions of
target genes, thereby controls their expression [14]. In sev-
eral studies, potent inhibitors of IKKs preventing NF-κB
activity through blockage of IκB release can be useful for
the treatment of inflammatory diseases such as rheuma-
toid arthritis (RA) [15-18].
Mitogen activated protein (MAP) kinases are a group of
signaling molecules that also appear to play important
roles in inflammatory processes. At least three MAP kinase
cascades; ERK (extracellular signal-regulated kinase), JNK
(c-Jun N-terminal kinase) and p38 are well described, and
have been reported to differentially activate depending on
the stimuli and cell types [19]. Several studies have dem-
onstrated that activation of MAP kinase is significant in
the regulation of inflammation via controlling the activa-
tion of NF-κB and IKKs [19-22].
In the present study, we therefore investigated whether
melittin and bee venom inhibit NF-κB via disrupting MAP
kinase signals, and thereby inhibit the inflammatory
response in Raw 264.7 macrophages and in the synovio-
cytes of rheumatoid arthritis patients.
Methods
Chemicals
Rabbit polyclonal antibodies to cPLA2 (dilution 1:500),
and goat polyclonal antibody to COX-2 (1:500), TNF-α
(1:500), p50 (1:500), p65 (1:500), IκBα (1:500), phos-
pho-IκBα (1:200), IκBβ (1:500) and mouse polyclonal
antibody to iNOS (1:500), IκB kinases (1:500), mouse
monoclonal phospho-ERK, phospho-JNK and phospho-
p38 antibodies (1:500), and rabbit polyclonal ERK, JNK
and p38 (1;500), and all of the secondary antibodies used
in Western blot analysis were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). T4 polynucleotide
kinase was obtained from Promega (Madison, WI). Poly
(dI·dC), horseradish peroxidase-labeled donkey anti-rab-
bit second antibody, and the ECL detection reagent were
obtained from Amersham Pharmacia Biotech (Centennial
Ave, NJ, USA). SNP, LPS, Griess reagent, monoclonal anti-
β-actin antibody, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphe-
nyl tetrazolium bromide (MTT) and melittin, a compo-
nent of bee venom were purchased from Sigma-Aldrich
(St. Louis, MO, USA). U0126 (ERK inhibitor, 1,4-
diamino-2,3-dicyano-1,4-bis (2-aminophenylthio)buta-
diene) and SP600125 (JNK inhibitor, anthra [1,9-cd]pyra-
zole-6 (2H)-one) were purchased from Calbiochem (San
Diego, CA, USA). Bee venom was purchased from You-
Miel BV Ltd (Hwasoon, Korea). The compositions are fol-
lowings: melittin (45–50%), apamin (2.5–3%), MCD
peptide (2–3%), PLA2 (12%), Lyso PLA (1%), hyaluroni-
dase (2–3%), histidine (1–1.5%), secarpin (0.5%), ter-
tiapin (0.1%), procamine (0.1%), amine (2–3%),
carbohydrate (4–5%), 6pp lipids (4–5%), and others
(19–27%, protease inhibitor, glucosidase, invertase, acid
phosphomonoesterase, dopamine, norepinephrine and
unknown amino acid).
Cell culture
Raw 264.7, a mouse macrophage-like cell line and THP-1,
a human monocytic cell line were obtained from the
American Type Culture Collection (Cryosite, Lane Cove
NSW, Australia). Dulbecco's modified Eagle medium
(DMEM), penicillin, streptomycin, and fetal bovine
serum were purchased from Gibco Life Technologies
(Rockville, MD, USA). Raw 264.7 cells were grown in
DMEM with 10% fetal bovine serum, 100 U/ml penicil-
lin, and 100 μg/ml streptomycin at 37°C in 5% CO2
humidified air. THP-1 cells were grown in RPMI 1640
with L-glutamine and 25 mM HEPES buffer (Gibco Life
Technologies, Rockville, MD, USA) supplemented with
10% fetal bovine serum, 100 units/ml penicillin and 100
μg/ml streptomycin at 37°C in 5% CO2 humidified air.Journal of Inflammation 2008, 5:7 http://www.journal-inflammation.com/content/5/1/7
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Synoviocyte culture
Synovial tissues were obtained, with consent, from nine
RA patients who were undergoing total knee replacement
or arthroscopic synovectomy. All patients satisfied the
1987 revised diagnostic criteria of the American College of
Rheumatology [23]. The method of synoviocyte culture
was described in elsewhere [4,5].
Determination of Nitric Oxide and Prostaglandin E2
The NO accumulation in the supernatant was assessed by
Griess reaction described in elsewhere [4], and the deter-
mination of PGE2 was performed as described in else-
where [4].
DNA binding activity of NF-κB
EMSA was performed according to the manufacturer's rec-
ommendations (Promega, Madison, WI) as described in
previous study [4,5]. Briefly, nuclear extract was incubated
with κB consensus oligonucleotides end-labeled using T4
polynucleotide kinase and [γ-32P] ATP for 10 min at
37°C. Gel shift reactions were assembled and allowed to
incubate at room temperature for 10 min followed by the
addition of 1 μl (50,000–200,000 cpm) of 32P-labeled
oligonucleotide and another 20 min of incubation at
room temperature. For the competition assay, 100× or
200× excesses of unlabeled double-stranded oligonucle-
otide of the κB binding site (or 100× irrelevant oligonu-
cleotide of AP-1 or SP-1) were used as specific
competitors. Supershift assay was done in the presence of
p50 or p65 subunit of NF-κB (2 μg). Subsequently 1 μl of
gel loading buffer was added to each reaction and loaded
onto a 4% nondenaturing gel and electrophoresed until
the dye was three-fourths of the way down the gel. The gel
was dried at 80°C for 1 hr and exposed to film overnight
at 70°C. The relative density of the protein bands was
scanned by densitometry using MyImage (SLB, Seoul,
Korea), and quantified by Labworks 4.0 software (UVP
Inc., Upland, California).
Transfection and assay of Luciferase activity
Raw 264.7 or THP-1 cells were transfected with pNF-κB-
Luc plasmid (5× NF-κB; Stratagene, CA, USA) using a mix-
ture of plasmid and lipofectAMINE PLUS in OPTI-MEN
according to manufacture's specification (Invitrogen,
Carlsbad, CA, USA). The control pCMV (Clontech, CA,
USA) was co-transfected to monitor the transfection effi-
ciency. After 24 hr, the cells were then co-treated with BV
(or melittin) and LPS or SNP. Luciferase activity was meas-
ured by using the luciferase assay kit (Promega) according
to the manufacturer's instructions (WinGlow, Bad Wild-
bad, Germany).
Western blot analysis
Cell lysates were prepared as described in the previous
study [12]. Equal amount of lysate proteins (80 μg) were
separated on a SDS/12%-polyacrylamide gel, and then
transferred to a nitrocellulose membrane (Hybond ECL,
Amersham Pharmacia Biotech Inc., Piscataway, NJ). Blots
were blocked for 2 hr at room temperature with 5% (w/v)
non-fat dried milk in Tris-buffered saline [10 mM Tris (pH
8.0) and 150 mM NaCl] solution containing 0.05%
tween-20. The membrane was incubated for 5 hr at room
temperature with specific antibodies. The blot was then
incubated with the corresponding conjugated anti-rabbit
immunoglobulin G-horseradish peroxidase (Santa Cruz
Biotechnology Inc.). Immunoreactive proteins were
detected with the ECL western blotting detection system.
The relative density of the protein bands was scanned by
densitometry using MyImage (SLB, Seoul, Korea), and
quantified by Labworks 4.0 software (UVP Inc., Upland,
California).
Immunofluorescence staining
Cells were plated in chambered tissue culture slides at a
density of 2 × 103 cells/well in DMEM. The Raw 264.7
cells were then cultured with serum-free medium contain-
ing LPS, BV and SP for 2 hr, and then the intracellular
location of p50 was determined by immunofluorescence
confocal scanning microscope (magnification, 630×) as
described in elsewhere [4]. Twenty-four hours later, the
cells were washed once with PBS and fixed with 4% para-
formaldehyde for 20 min, membrane-permeabilized by
exposure for 2 min to 0.1% Triton ×-100 in phosphate-
buffered saline, and placed in blocking serum (5% bovine
serum albumin in phosphate-buffered saline) at room
temperature for 1 hr. The cells were then exposed to pri-
mary polyclonal antibodies for p50 (1:100 dilution) over-
night at 4°C, After washes with ice-cold PBS followed by
treatment with anti-goat- or anti- rabbit- biotinylated sec-
ondary antibodies Alexa Fluor 568 (p50) or Alexa Fluor
633 (DAPI) (Molecular Probes Inc., Eugene, OR, USA),
1:200 dilution, for 4 hr at room temperature. Nuclear
stain and mount in antifade medium with DAPI (Vector
Laboratory Inc.), immunofluorescence images were
acquired using a confocal laser scanning microscope (TCS
SP2, Leica Microsystems AG, Wetzlar, Germany)
equipped with a 630×oil immersion objective.
Statistical analysis
Data were analyzed using one-way analysis of variance
followed by Tukey's test as a post hoc test. Differences
were considered significant at p < 0.05.
Results
Melittin inhibited LPS and SNP-induced activation of JNK 
in RAW 264.7 cells
We previously found that bee venom and its major com-
ponent, melittin inhibits LPS, TNF-α and SNP-induced
inflammatory responses through inactivation of NF-κB
and IKKs signals [4,5]. The MAPK pathway is known toJournal of Inflammation 2008, 5:7 http://www.journal-inflammation.com/content/5/1/7
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play an important role in the transcriptional regulation of
LPS-induced iNOS and COX-2 expression via suppression
of the activation of transcription factor NF-κB. To investi-
gate the involvement of MAP kinase pathway in the inhib-
itory effect by melttin and bee venom on NO and PGE2
production, the activation of MAP kinase (phosphoryla-
tion of ERK, JNK and p38) induced by LPS and SNP was
evaluated in both Raw 264.7 cells as well as synoviocytes.
The densitometry analysis from individual three different
experiments showed that melittin (0.5–5 μg/ml) and bee
venom (5 and 10 μg/ml) strongly blocked LPS (1 μg/ml)
and SNP (200 μM)-induced activation of JNK in the Raw
264.7 cells (Fig. 1A) as well as synoviocytes (Fig. 1B). We
also found that significant inhibitory effects of melittin
(0.5–5 μg/ml) on the activation of ERK in LPS treated Raw
264.7 cells and synoviocytes, and SNP treated synovio-
vytes. Activation of p38 was also significantly reduced in
the LPS treated synoviocytes, and SNP treated Raw 264.7
cells and synoviocytes, but the expression ERK and p38
was also reduced, indicating that blocking of the activa-
tion of p38 and ERK was not specific (Fig. 1A and 1B).
Similar effect of bee venom was also found (Fig. 1). These
results suggest that JNK could be the most specific and
important signal involved in the melittin and BV-induced
inhibition of NO and PGE2 generation.
Effect of melittin and bee venom on LPS and SNP-induced phosphorylation of MAPKs Figure 1
Effect of melittin and bee venom on LPS and SNP-induced phosphorylation of MAPKs. A, Raw 264.7 macrophages 
were treated with 5 or 10 μg/ml melittin or 0.5–5 μg/ml bee venom in the presence of LPS (1 μg/ml) or SNP (200 μM) at 37°C 
for 24 hr. B, Synoviocytes were treated with 5 or 10 μg/ml melittin or 0.5–5 μg/ml bee venom in the presence of 1 μg/ml LPS 
or 200 μM SNP at 37°C for 24 hr. Equal amounts of total proteins (80 μg/lane) were subjected to 10% SDS ± PAGE, and the 
expression of p-ERK/ERK, p-JNK/JNK, or p-p38/p38 were detected by western blotting using specific antibodies. Each panel 
representative of three independent experiments. Quantification of band intensities from three independent experimental 
results was determined by a densitometry (Imaging System). Data was described as means ± S.E. from three experiments per-
formed in triplicate for p-ERK/ERK, p-JNK/JNK, or p-p38/p38. *p < 0.05 indicate statistically significant differences from the 
LPS or SNP-treated group.
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JNK inhibitor suppressed the inhibitory effects of melittin 
and bee venom on NF-κB dependent Luciferase and DNA 
binding activity
To further examine the involvement of JNK pathway in
the inhibitory effect of melittin and bee venom on NF-κB
activation, we explored JNK specific inhibitor SP600125
(10–50  μM), and determined the inhibitory effect of
melittin and bee venom on the activation of NF-κB. As
shown in Fig. 2, pretreatment (1 hr) of SP600125 strongly
suppressed the inhibitory effect of melittin and bee
venom on the LPS and SNP-induced NF-κB activation in
Raw 264.7 cells (Fig. 2A) and synoviocytes (Fig. 2B). The
specificity of DNA binding was examined by competition
assay by adding an excessive amount of unlabeled/cold
oligonucleotides to reaction mixtures containing nuclear
extract. The specificity of DNA binding was examined by
supershift assay using antibodies for the p50 or p65 com-
ponents of NF-κB (data not shown).
One of the consequences of inhibition of NF-κB is the
inhibition of the nuclear translocation of p50 and p65
through the blockage of IκB release. To study the result of
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the NF-κB DNA binding activity induced by LPS or  SNP Figure 2
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the NF-κB DNA binding activity 
induced by LPS or SNP. Raw 264.7 macrophages (A) and synoviocytes (B) were pretreated with 10, 20, and 50 μM 
SP600125 1 h prior to the treatment with melittin or bee venom with or without LPS or SNP for 2 h. The DNA binding activa-
tion of NF-κB was investigated using EMSA. Nuclear extracts from Raw 264.7 cells or synoviocytes treated for 1 hr were incu-
bated with 32P-end-labeled oligonucleotide containing the κB sequence. Each panel is representative of three similar 
experiments with duplicates.
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the treatment of JNK inhibitor on the translocation of p50
and p65 into the nucleus, we determined the appearance
of the p50 and p65 in the nucleus extracts by Western
blott. Pretreatment (1 hr) of SP600125 suppressed the
inhibitory effect of melittin and bee venom on LPS and
SNP-induced nuclear translocation of the p50 and p65 in
Raw 264.7 cells (Fig. 3A) and in synoviocytes (Fig. 3B). Te
kinetics of IκBα release (determined the level of IκBα
phosphorylation) in cytosol were further studied by west-
ern blot analysis. Inhibitory effect of melittin and bee
venom on the LPS as well as SNP-induced IκBα release
was markedly suppressed by SP600125 in both Raw 264.7
cells (Fig. 3A) and synoviocytes (Fig. 3B). The phosphor-
ylation of IκBβ was not examined because this antibody is
not commercially available. The suppressive effect of
SP600125 on the reduced nuclear translocation of the p50
subunits was also confirmed by examination with confo-
cal laser scanning microscopy in Raw 264.7 cells (Fig. 3C).
Raw 264.7 and THP-1 cells were transfected with a pro-
moter reporter gene construct (a fusion gene containing
SV40 promoter, 5 repeats of the consensus NF-κB binding
sequence), and transcriptional activities were also meas-
ured after stimulating the cells with LPS or SNP in the
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the nuclear translocation of the p50 subunit and  the release of IκB induced by LPS or SNP Figure 3
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the nuclear translocation of the p50 subunit and 
the release of IκB induced by LPS or SNP. Raw 264.7 cells (A) or synoviocytes (B) were pretreated with 10 and 20 μM 
SP600125 1 h prior to the treatment with melittin or bee venom with or without LPS (1 μg/ml) or SNP (200 μM) at 37°C for 
24 hr. 80 μg of nuclear (p50 and p65), cytosolic IκB or total protein extracted after treatment were used to determine of p50, 
p65, p-IκBα, IκBα, or IκBβ; β-actin protein was used as an internal control. Each panel is representative of three similar exper-
iments. C, Raw 264.7 cells were treated with LPS, BV and SP for 24 hr, and then the intracellular location of p50 was deter-
mined by immunofluorescence confocal scanning microscope (magnification, 630×). Double staining (Merge, pink) with p50 
(red) and DAPI (blue) staining demonstrates the localization of p50 in the nucleus.
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presence of bee venom and melittin. Agreement with the
suppressive effect of SP600125 on the DNA binding activ-
ity of NF-κB, pretreatment (1 hr) of SP600125 also
strongly suppressed the inhibitory effect of melittin and
bee venom on the LPS or SNP-induced NF-κB transcrip-
tional activation in Raw 264.7 cells (Fig. 4A) and THP-1
cells (Fig. 4B). These suppressive effects were statistically
significant in the inhibitory effect of melittin and Bee
venom on the LPS and SNP-induced NF-κB transcrip-
tional activation in both Raw 264.7 cells (Fig. 4A) and
THP-1 cells (Fig. 4B) by 20 μM of SP600125. The suppres-
sive effects were also statistically significant in the inhibi-
tory effect of Bee venom on the LPS-induced, and in the
inhibitory effect of melittin on the SNP-induced NF-κB in
THP-1 cells by 10 μM of SP600125.
JNK inhibitor suppressed the inhibitory effects of melittin 
and bee venom on iNOS and COX-2 expression, and on 
NO and PGE2 generation
To investigate whether the suppressed effect of SP600125
on the inhibitory effect of bee venom and melittin on the
inflammatory gene expression, iNOS and COX-2 expres-
sion was determined. The inhibitory effect of melittin and
bee venom on iNOS and COX-2 expression by LPS and
SNP in Raw 264.7 cells (Fig. 5A) and in synoviocytes (Fig.
5B) were dose dependently suppressed by SP600215 (10
and 20 μM). The suppressive effect of SP600125 on the
inflammatory mediator generation was then examined.
Significant concentration-dependent suppression by the
pretreatment of SP600215 on the NO generation was
observed in Raw 264.7 cells (Fig. 6A,C) and synoviocytes
(Fig. 6B,D) treated with melittin and bee venom in com-
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the on NF-κB-dependent luciferase induced by LPS  or SNP Figure 4
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the on NF-κB-dependent luciferase induced by LPS 
or SNP. Raw 264.7 cells (A) and THP-1 cells (B) were transfected with pNF-κB-Luc plasmid (5× NF-κB), Raw 264.7 cells or 
THP-1 cells were pretreated with 10 and 20 μM SP600125 1 hr prior to the treatment with melittin or bee venom with or 
without LPS (1 μg/ml) or SNP (200 μM) at 37°C for 2 hr, and then luciferase activities were determined. All values represent 
means ± S.E. of three independent experiments performed in triplicate.
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bination with LPS (Fig. 6A,B) and SNP (Fig. 6C,D). Signif-
icant concentration-dependent suppressive effect by the
pretreatment of SP600215 (10 and 20 μM) on the PGE2
generation was also observed in Raw 264.7 cells (Fig.
7A,C) and synoviocytes (Fig. 7B,D) treated with melittin
and bee venom in combination with LPS (Fig. 7A,C) and
SNP (Fig. 7B,D).
Discussion
We previously found that bee venom and its major com-
ponent, melittin inhibits inflammatory stimuli such as
LPS, TNF-α, and SNP-induced NF-κB activation by pre-
venting p50 translocation via an interaction between
melittin and sulfhydryl group of p50 and/or IKKα and
IKKβ, and that these inhibit inflammatory reaction in the
development of rheumatoid arthritis [4,5]. In the present
study, we further found that melittin and bee venom sig-
nificantly reduced inflammatory stimuli (LPS and SNP)-
induced activation of JNK signal, and the JNK signal spe-
cific inhibitor SP600215 suppressed the inhibitory effect
of melittin and bee venom on the NF-κB activation, and
inflammatory reaction in Raw 264.7 macrophages and
synoviocytes obtained from rheumatoid arthritis patients.
This data reflected that the inhibition of JNK pathway
JNK inhibitor suppressed inhibitory effect of melittin and bee venom on the inflammatory gene expression induced by LPS or  SNP Figure 5
JNK inhibitor suppressed inhibitory effect of melittin and bee venom on the inflammatory gene expression 
induced by LPS or SNP. Raw 264.7 cells (A) or synoviocytes (B) were pretreated with 10 and 20 μM SP600125 1 hr prior 
to the treatment with melittin or bee venom with or without LPS (1 μg/ml) or SNP (200 μM) at 37°C for 24 hr. Equal amounts 
of total proteins (80 μg/lane) were subjected to 10% SDS ± PAGE, and the expression of iNOS, COX-2 and β-actin were 
detected by western blotting using specific antibodies. Each panel representative of three independent experiments.
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conjunction with inhibition of NF-κB pathway may also
contribute to the inhibitory effect of melittin and bee
venom on the inflammatory reaction of arthritis rheuma-
tism.
LPS and SNP rapidly phosphorylates ERK, p38 and JNK,
which lead to NF-κB activation in macrophages [24,25].
The activation of this MAP kinase leads an increase in the
production of pro-inflammatory mediators such as NO
and PGE2 [26,27]. Several studies have demonstrated the
implication of the activation of MAP kinase in LPS-
induced iNOS and COX-2 expression [28-30] and the acti-
vation of NF-κB [30-33]. To demonstrate other pathway
of NF-κB inactivation by melittin and bee venom, we
investigated the relationship between NF-κB and MAP
kinase activation. Our data demonstrated that melittin
and bee venom reduces LPS and SNP-induced activation
of JNK signals. Even though other signals (p38 MAP
kinase and ERK signal) may be also interfered by melittin
and bee venom depend on the cell types and stimuli, LPS
and SNP-induced JNK signal was specifically inhibited by
melittin and bee venom. This finding is agreed with other
data showing that JNK pathway is important signal in the
activation of NF-κB in the processes of inflammatory reac-
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the generation of NO induced by LPS or SNP Figure 6
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the generation of NO induced by 
LPS or SNP. Raw 264.7 cells (A, C) or synoviocytes (B, D) were pretreated with 10 and 20 μM SP600125 1 hr prior to the 
treatment with melittin or bee venom with or without LPS (1 μg/ml) or SNP (200 μM) at 37°C for 24 hr. The amounts of NO 
in the medium of cultured Raw264.7 cells (A, C) or synoviocytes (B, D) were determined by the methods described in the 
methods. Results are expressed as means ± SE of three independent experiments performed in triplicate. * indicates signifi-
cantly different from the LPS or SNP treated groups (p < 0.05). # and ##, indicates significantly different from LPS or SNP + 
melittin or BV treated group (p < 0.05).
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tion [29,30,34]. In more precise investigation with spe-
cific JNK inhibitor SP600215, we further showed that the
combination treatment of JNK inhibitor with bee venom
and melittin suppressed inhibitory effects of melittin and
bee venom on the LPS and SNP-induced NO and PGE2
release with the suppressed effect on the inhibitory effect
of melittin and bee venom on the NF-κB DNA binding
and transcriptional activities. Moreover, we also showed
that JNK inhibitor SP600215 abrogated the inhibitory
effect of melittin and bee venom on the LPS and SNP-
induced translocation of NF-κB by western blotting as
well as translocation of p50, a subunit of NF-κB by confo-
cal microscope observation. These data show that specific
inhibition of JNK pathway may be important for inactiva-
tion of NF-κB, and thus inhibitory effects of melittin and
bee venom on the LPS and SNP-induced NO and PGE2
production.
The involvement of MAPK pathways in the biological
activities of melittin and bee venom has been demon-
strated. Bee venom triggered the activation of p38 MAPK
and JNK and increased lactate dehydrogenase (LDH)
release in the bee venom-induced apoptosis of human
leukemic U937 [35]. Very similar to our finding, Jang et
al. showed that bee venom inhibited mRNA level of
iNOS, COX-2 and NF-κB paralleled with inhibition of
mRNA level of MAP kiase induced by LPS [36]. In addi-
tion, we also found that bee venom and melittin inhibited
platelet-derived growth factor BB (PDGF-BB)-induced
smooth muscle cell proliferation through inactivation of
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the generation of PGE2 induced by LPS or SNP Figure 7
JNK inhibitor suppressed the inhibitory effect of melittin and bee venom on the generation of PGE2 induced by 
LPS or SNP. Raw 264.7 cells (A, C) or synoviocytes (B, D) were pretreated with 10 and 20 μM SP600125 1 hr prior to the 
treatment with melittin or bee venom with or without LPS (1 μg/ml) or SNP (200 μM) at 37°C for 24 hr. The amounts of PGE2 
in the medium of cultured Raw264.7 cells (A, C) or synoviocytes (B, D) were determined by the methods described in the 
methods. Results are expressed as means ± SE of three independent experiments performed in triplicate. * indicates signifi-
cantly different from the LPS or SNP treated groups (p < 0.05). # and ##, indicates significantly different from LPS or SNP + 
melittin or BV treated group (p < 0.05).
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NF-κB via inhibition of ERK pathway [37]. These results
suggest that, the cross talking between the MAP kinase
and the NF-κB signals may be important for relaying the
biological effect of melittin and bee venom. Several stud-
ies have been reported the cross talking between MAP
kinase signals and NF-κB signals. Minutoli et al., demon-
strated the abrogation of JNK and p38 signals, but
enhancement of ERK 1/2 activity by disruption of the
transcriptional factor NF-κB in the development of testic-
ular ischemia-reperfusion injury [38]. It was also found
that TNF-induced NF-κB activation was abrogated in cells
deleted of MKK4 gene which is a dual-specificity kinase
that activates both JNK and p38 MAPK [39].
Differential MAPK pathways in the activation of NF-κB
can be activated depend upon cell types and stimuli as
well as biological activities. It is noteworthy that a NF-κB
inducing kinase activates NF-κB transcriptional activity
through a p38 MAPK-dependent RelA phosphorylation
pathway in the induction of pro-inflammatory gene
expression [40]. However, agreement with our finding, de
Haij et al., demonstrated that NF-κB mediated IL-6 pro-
duction by renal epithelial cells in the tubulointerstitial
inflammation, a hallmark of most renal diseases is regu-
lated by JNK [41]. JNK pathway is also involved in IL-6
gene expression by enhancing NF-κB activity in human
monocytes [42], as well as induction of proinflammatory
responses in macrophages by the glycosylphosphatidyli-
nositols of Plasmodium falciparum [43]. Taken together,
our data indicate that inhibition of JNK signal is the most
involved in the inhibitory effect of melittin and bee
venom on the LPS and SNP-induced activation of NF-κB
as well as in the production of NO and PGE2. In inflam-
matory diseases, PGs and NO contribute to the patho-
physiology of local and chronic inflammation [44-47].
The promoter region of the murine gene encoding iNOS
and COX-2 contains NF-κB binding sites [15,48], which
suggests that the inhibitory effect of inflammatory gene
expression is related with the inhibition of the DNA bind-
ing activity of NF-κB. The therapeutic potential of the
inhibition of NF-κB activity has been recognized as an
effective anti-inflammatory treatment strategy against the
progression of arthritis [49]. Therefore, the present data
show that inhibition of JNK pathway may also contribute
to the anti-inflammatory and anti-arthritis effects of
melittin and bee venom, and cross talking between JNK
and NF-κB signals may be important anti-inflammatory
mechanism of melittin and bee venom.
Conclusion
These data show that melittin and bee venom prevent LPS
and SNP-induced NO and PGE2 production via JNK path-
way dependent inactivation of NF-κB, and suggest that
inactivation of JNK pathways may also contribute to the
anti-inflammatory and anti-arthritis effects of melittin
and bee venom.
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